Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study.
<h4>Introduction</h4>Early identification of Alzheimer's disease (AD) is needed both for clinical trials and in clinical practice. In this study, we compared brief cognitive tests and cerebrospinal fluid (CSF) biomarkers in predicting conversion from mild cognitive impairment (MCI)...
Guardado en:
Autores principales: | Sebastian Palmqvist, Joakim Hertze, Lennart Minthon, Carina Wattmo, Henrik Zetterberg, Kaj Blennow, Elisabet Londos, Oskar Hansson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b5dbae0769b54b33891d9cbeaf202486 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Solitary living in Alzheimer’s disease over 3 years: association between cognitive and functional impairment and community-based services
por: Wattmo C, et al.
Publicado: (2014) -
Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis
por: Niklas Mattsson, et al.
Publicado: (2016) -
Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
por: Niklas Mattsson-Carlgren, et al.
Publicado: (2021) -
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
por: Niklas Mattsson-Carlgren, et al.
Publicado: (2020) -
Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics.
por: Eugenia Trushina, et al.
Publicado: (2013)